Vishal Chandra Selected Research

Vishal Chandra Research Topics

Disease

16	Neoplasms (Cancer) 12/2023 - 06/2013
8	Endometrial Neoplasms (Endometrial Cancer) 11/2023 - 06/2013
6	Breast Neoplasms (Breast Cancer) 08/2023 - 06/2009
2	Hyperplasia 01/2016 - 10/2011
2	Adenocarcinoma 01/2016 - 06/2013
1	Ovarian Neoplasms (Ovarian Cancer) 12/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Zika Virus Infection 05/2018
1	Uterine Cervical Dysplasia 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 02/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2016
1	Gallbladder Neoplasms (Gallbladder Cancer) 02/2016
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 11/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 10/2014
1	Carcinogenesis 06/2013
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2012
1	Bone Resorption 06/2012

Drug/Important Bio-Agent (IBA)

5	(((4- nitrophenyl)amino)(2,2,4,4- tetramethyl thiochroman-6-yl)amino) methane-1-thioneIBA 12/2023 - 01/2018
5	Estrogen ReceptorsIBA 10/2014 - 10/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2015
3	Cyclin D1IBA 12/2023 - 06/2013
3	Selective Estrogen Receptor Modulators (SERM)IBA 11/2013 - 10/2009
3	PyransIBA 11/2013 - 10/2011
2	EnzymesIBA 01/2022 - 10/2014
2	mortalinIBA 01/2022 - 05/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 05/2020
2	Biomarkers (Surrogate Marker)IBA 11/2016 - 02/2016
2	Estrogens (Estrogen)FDA Link 01/2016 - 11/2013
2	ChromatinIBA 11/2015 - 01/2014
2	CDRI 85-287 (PEPP)IBA 11/2013 - 01/2013
2	BenzopyransIBA 11/2013 - 01/2013
2	Estradiol (Delestrogen)FDA LinkGeneric 10/2011 - 06/2009
1	Coloring Agents (Dyes)IBA 08/2023
1	Deoxyglucose (2 Deoxy D glucose)IBA 08/2023
1	Niclosamide FDA Link 05/2023
1	AgarIBA 05/2023
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Apoptosis Inducing FactorIBA 01/2022
1	Investigational DrugsIBA 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	CaspasesIBA 01/2022
1	CateninsIBA 05/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 05/2021
1	MTOR InhibitorsIBA 05/2020
1	Phosphotransferases (Kinase)IBA 05/2020
1	sulforaphaneIBA 05/2020
1	VaccinesIBA 05/2018
1	Suppositories (Vaginal Suppositories)IBA 01/2018
1	AntigensIBA 02/2016
1	MicroRNAs (MicroRNA)IBA 02/2016
1	Small Untranslated RNAIBA 02/2016
1	Progesterone FDA LinkGeneric 01/2016
1	Tamoxifen FDA LinkGeneric 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 11/2015
1	Monoclonal AntibodiesIBA 09/2015
1	Protein SIBA 09/2015
1	SteroidsIBA 10/2014
1	Androgen Receptors (Androgen Receptor)IBA 10/2014
1	Steroid Receptors (Steroid Receptor)IBA 10/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2013
1	Glutathione (Reduced Glutathione)IBA 06/2013
1	p38 Mitogen-Activated Protein KinasesIBA 06/2013
1	PolyphenolsIBA 06/2013
1	TeaIBA 06/2013
1	Epidermal Growth Factor (EGF)IBA 01/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2013
1	Cholecystokinin (Pancreozymin)IBA 12/2012
1	Cholecystokinin B ReceptorIBA 12/2012
1	Hormones (Hormone)IBA 12/2012
1	triphenylethyleneIBA 06/2012
1	ormeloxifeneIBA 06/2012
1	Benzene (Benzole)IBA 06/2009

Therapy/Procedure

5	Therapeutics 11/2023 - 12/2012
1	Oral Administration 12/2023
1	Immunotherapy 11/2023
1	Drug Therapy (Chemotherapy) 05/2021
1	Chemoprevention 01/2018
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2016
1	Conservative Treatment 01/2016
1	Adjuvant Chemotherapy 11/2015
1	Ovariectomy (Oophorectomy) 06/2012